Facebook
Instagram
Linkedin
Twitter
Vimeo
Home
Single Company Reports
Investment Trust Centre
Market Reports & Share Ideas
Members
Events
News
Shares
Features
Commodities/FX
Private Equity & Venture Capital
Tax-Efficient Guides
Property
Podcasts
Video
Awards
Account
Login
Become Member
Search
Facebook
Instagram
Linkedin
Twitter
Vimeo
Become Member
Login
Account
Search
Home
Premium
Reports
Single Company Reports
Market Reports & Share Ideas
Tax-Efficient Guides
News
Funds & Trusts
Commodities & FX
Private Equity & Venture Capital
Property
Politics
Shares
Features
Compare
ISA Comparison Table
Podcasts
Video
Events
Awards
Investment Trust Centre
Home
Premium
Reports
Single Company Reports
Market Reports & Share Ideas
Tax-Efficient Guides
News
Funds & Trusts
Commodities & FX
Private Equity & Venture Capital
Property
Politics
Shares
Features
Compare
ISA Comparison Table
Podcasts
Video
Events
Awards
- Advertisment -
Tags
ImmuPharma
Tag:
ImmuPharma
Shares
AIM weekly movers: Spectral MD Nasdaq reversal
Andrew Hore
-
16/04/2023
4
Shares
AIM movers: Verici Dx continues recovery and Scotgold Resources low ore grades
Andrew Hore
-
27/03/2023
0
Shares
AIM movers: Pressure Technologies contract and IOG admits Southwark well uncommercial
Andrew Hore
-
06/02/2023
0
Shares
AIM movers: Croma Security falls, while Tlou Energy gets cash injection
Andrew Hore
-
11/11/2022
1
Shares
AIM movers: Naked Wines late night warning and ITM Power boss to depart
Andrew Hore
-
14/09/2022
0
Shares
AIM movers: Falanx rebounds and ex-dividends
Andrew Hore
-
04/08/2022
1
Shares
Aim movers: CareTech, Verditek, Inspirit Energy, Caspian Sunrise, Immupharma
Andrew Hore
-
27/06/2022
0
Shares
ImmuPharama shares fall on widened £8.2m loss
Natasha Doris
-
25/05/2022
0
1
2
Page 2 of 2
Most Read
AIM movers: Trellus Health partners with Johnson & Johnson and Thruvision strategic review
14/01/2025
FTSE 100 ticks marginally higher as housebuilders rise
14/01/2025
Persimmon shares jump as completions rise
14/01/2025
Share Tip: Ramsdens Holdings – record set of Finals see brokers increasing their Target Price to 320p a share, against current 235p on just...
14/01/2025